Featured News Image Knight Initiative news | May 12 2026 Stanford Report Gift advances research into brain resilience and aging A $90 million gift from Penny and Phil Knight will extend the work of the Knight Initiative for Brain Resilience at Stanford’s Wu Tsai Neurosciences Institute Image Research news | May 12 2026 Knight Initiative for Brain Resilience In pursuit of brain resilience In this research roundup, we look back on some of the ways Knight Initiative scientists have been pursuing ways to keep our minds sharp well into old age Image Researcher profiles | Apr 27 2026 Wu Tsai Neurosciences Institute Q&A: Could neuroscience help explain miscarriage? Pregnancy complications such as miscarriage spike after age 35. Wu Tsai Neuro postdoc Blake Laham suspects neural signaling in the uterus is partly to blame Image Researcher profiles | Apr 2 2026 Wu Tsai Neurosciences Institute Q&A: ‘To see is to believe’ Faculty Scholar Guosong Hong says that light plays a key role in neuroscience and—and that’s why he’s working with a Big Ideas in Neuroscience team to make transparent brains News Filter & Sort Sort by ThemeNeuroHealth News TypeResearch news Press coverage Sort by Newest to oldest Oldest to newest Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine. Image Research news | Aug 29 2018 Stanford Medicine - Scope Opioid system plays key role in ketamine’s antidepressant effects, Stanford stud... For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc Image Research news | May 22 2017 Stanford Medicine - Scope Stanford researcher explores use of ketamine to treat severe mental illness Stanford researcher Carolyn Rodriguez, MD, PhD, was the first to explore ketamine as a treatment for OCD. Image Press coverage | Jul 29 2016 The Guardian From ketamine to cupboard therapy: the future of mental health treatment With big pharma short on solutions, we talk to people pioneering new ways to beat conditions including anxiety, depression and schizophrenia.
Image Knight Initiative news | May 12 2026 Stanford Report Gift advances research into brain resilience and aging A $90 million gift from Penny and Phil Knight will extend the work of the Knight Initiative for Brain Resilience at Stanford’s Wu Tsai Neurosciences Institute
Image Research news | May 12 2026 Knight Initiative for Brain Resilience In pursuit of brain resilience In this research roundup, we look back on some of the ways Knight Initiative scientists have been pursuing ways to keep our minds sharp well into old age
Image Researcher profiles | Apr 27 2026 Wu Tsai Neurosciences Institute Q&A: Could neuroscience help explain miscarriage? Pregnancy complications such as miscarriage spike after age 35. Wu Tsai Neuro postdoc Blake Laham suspects neural signaling in the uterus is partly to blame
Image Researcher profiles | Apr 2 2026 Wu Tsai Neurosciences Institute Q&A: ‘To see is to believe’ Faculty Scholar Guosong Hong says that light plays a key role in neuroscience and—and that’s why he’s working with a Big Ideas in Neuroscience team to make transparent brains
Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.
Image Research news | Aug 29 2018 Stanford Medicine - Scope Opioid system plays key role in ketamine’s antidepressant effects, Stanford stud... For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc
Image Research news | May 22 2017 Stanford Medicine - Scope Stanford researcher explores use of ketamine to treat severe mental illness Stanford researcher Carolyn Rodriguez, MD, PhD, was the first to explore ketamine as a treatment for OCD.
Image Press coverage | Jul 29 2016 The Guardian From ketamine to cupboard therapy: the future of mental health treatment With big pharma short on solutions, we talk to people pioneering new ways to beat conditions including anxiety, depression and schizophrenia.
